Adamas Pharmaceuticals, Inc.

Home » Adamas Pharmaceuticals, Inc.

Secondary

Adamas Pharmaceuticals, Inc.

Adamas is a pharmaceutical company committed to developing and commercializing products and product candidates for the treatment of chronic neurological disorders.

Symbol

ADMS

Last Closing Price
$42.65

Shares
2,100,000

Effective Date
January 24, 2018

Underwriters
BofA Merrill Lynch, Leerink, Evercore ISI

To view the prospectus for Adamas Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253